Home - Clinical Trials Arena
WEBAlio starts trial to expand label for remote monitoring device. The CAVA study is expected to validate the use of SmartPatch technology. More themes. Artificial Intelligence. Cloud. Corporate Governance. Cybersecurity. Environmental Sustainability. Internet of Things.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Pfizer and BioNTech’s Covid-19/flu ... - Clinical Trials Arena
WEBAug 16, 2024 · Pfizer and BioNTech have announced that a Phase III trial studying their investigational combination mRNA vaccine for the treatment of influenza and Covid-19 has failed to meet one of its two primary endpoints.. While the vaccine demonstrated a trend of higher responses in neutralising the influenza A strain compared to a licensed influenza vaccine, it failed to demonstrate non-inferiority ...
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Viridian Therapeutics' stock jumps after Phase III trial met all …
WEBSep 11, 2024 · The news saw the Massachusetts-based company’s stock price rise by 32% on 10 September, having closed at $14.19 on 9 September and $18.75 on 10 September. The trial met the primary and all secondary endpoints at 15 weeks after five infusions of veligrotug, showing highly statistically significant improvements in …
Antengene doses first subject in Phase I cancer antibody trial
WEBDec 12, 2023 · Chinese biopharmaceutical company Antengene has dosed the first subject in its Phase I PERFORM clinical trial of anti-CD24 monoclonal antibody, ATG-031, to treat advanced solid tumour or B-cell non-Hodgkin’s lymphoma (B-NHL) patients. In May this year, the company obtained US Food and Drug Administration clearance for …
Penn Medicine, UC San Diego team get funds for Alzheimer's trials
WEBAug 21, 2024 · In a study in mouse models, the drug could reverse Alzheimer’s disease symptoms. CNDR-51997 was detected under a drug discovery programme, jointly conducted by Penn Medicine and UC San Diego, with initial funding support from the NIA. With this additional funding, the team will conduct formal safety studies as required by the US Food and Drug ...
ProKidney drops Phase III CKD study to focus on US market and …
WEBSep 4, 2024 · The trials enrol patients with type 2 diabetes and chronic kidney disease (CKD). CKD can be a complication of type 2 diabetes. Credit: NTshutterth via Shutterstock. ProKidney is dropping an ex-US Phase III study for its chronic kidney disease (CKD) cell therapy rilparencel, following discussions ...
Scholar Rock gets FDA nod to trial SMA drug with GLP-1ra in obesity
WEBJan 24, 2024 · Scholar Rock will be initiating a Phase II trial of its spinal muscular atrophy pipeline drug apitegromab alongside a GLP-1 receptor agonist (GLP-1ra) in patients with obesity months after being given the green light by the US Food and Drug Administration (FDA). The company had its investigational new drug (IND) application for the myostatin ...
Hepatitis B: Four trials to watch over the next 12 months
WEBJul 28, 2023 · Hepatitis B immune globulin (Hepatect, Nabi-HB, Zutectra, Neohepatect, Fovepta) contains mainly immunoglobulin G and acts as passive immunising preparation. The two cohorts are HBsAg positive and HBeAg negative, with one group having had no treatment while the other group will have been treated with anti-HBV NUC for at least 12 months before ...